$SCLX Income Statement | Understand Stock

$SCLX

$2.05 -$0.28 (12.02%) Close

$SCLX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations and Comprehensive Loss

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net Revenue
Operating costs and expenses:
Cost of revenue
Research and development
Selling, general and administrative
Goodwill impairment
Intangible amortization
Legal settlements
Total net operating costs and expenses
Loss from operations
Change in fair value of warrants
Loss on initial issuance of private warrants
Change in fair value of conversion option liability
Other (income) expense:
(Gain) loss on derivative liability
Change in fair value of debt and liability instruments
Gain on debt extinguishment, net
Scilex Pharma Notes principal increase
Transaction costs allocated to warrant liabilities
Interest earned on investments held in Trust Account
Total other income, net
Interest expense, net
Loss on foreign currency exchange
Unrealized loss on digital assets, net
Loss on debt extinguishment, net
Realized loss on digital assets, net
Unrealized (gain) on equity investment, net
Realized (gain) on equity investments, net
Unrealized (gain) on equity method investments carried at fair value, net
Realized (gain) on equity method investments carried at fair value, net
Realized (gain) on securities
Total other (income) expense, net
Loss before income taxes
Income tax expense (benefit)

Net loss
Basic weighted average shares outstanding, ordinary shares (in Shares)
Net Loss Attributable to Common Stockholders Before Deemed Dividend
Deemed dividend
Net loss attributable to noncontrolling interests
Net Income (Loss) Available to Common Stockholders, Basic, Total
Other comprehensive income:
Foreign currency translation adjustment
Changes in fair value attributable to instrument-specific credit risk
Total other comprehensive income
Comprehensive loss attributable to common stockholders
Net comprehensive loss attributable to common stockholders
Earnings Per Share
Net loss per share attributable to common stockholders - basic
Net loss per share attributable to common stockholders - diluted
Diluted weighted average shares outstanding, ordinary shares (in Shares)
Diluted net income (loss) per share, ordinary shares (in Dollars per share)

Weighted Average Number of Shares Outstanding, Diluted
Weighted average number of shares during the period-basic
Weighted average number of shares, diluted

Comments